Analogic Corporation (NASDAQ:ALOG) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday. The firm currently has a $93.00 price target on the medical research company’s stock. Zacks Investment Research‘s target price would suggest a potential upside of 12.25% from the company’s previous close.

According to Zacks, “Analogic Corporation designs, manufactures, and sells medical imaging, ultrasound, and security systems and subsystems to original equipment manufacturers (OEMs) and end users primarily for the healthcare and airport security markets. Its operates in three segments, Medical Imaging, Ultrasound, and Security and Detection. The Medical Imaging segment provides medical imaging systems and subsystems, including computed tomography (CT) detector systems, data acquisition systems, data management systems, and integrated CT gantries, and digital mammography products consisting of detector plates, as well as motion control devices for use in computer-controlled automation systems. The Ultrasound segment designs and manufactures medical ultrasound systems under the BK Ultrasound brand for use in urology, surgery, point-of-care, anesthesia, and general imaging applications. The Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications. “

Separately, Jefferies Group LLC reiterated a “hold” rating and set a $75.00 target price on shares of Analogic Corporation in a report on Wednesday, September 20th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $85.25.

Analogic Corporation (NASDAQ:ALOG) remained flat at $82.85 during trading on Tuesday. 42,729 shares of the stock were exchanged. Analogic Corporation has a 52-week low of $66.00 and a 52-week high of $95.85. The stock’s market cap is $1.03 billion. The company’s 50-day moving average price is $76.91 and its 200-day moving average price is $72.91.

TRADEMARK VIOLATION NOTICE: “Zacks Investment Research Upgrades Analogic Corporation (ALOG) to Buy” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/10/10/zacks-investment-research-upgrades-analogic-corporation-alog-to-buy.html.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. grew its position in shares of Analogic Corporation by 54,561.6% in the 1st quarter. BlackRock Inc. now owns 1,601,037 shares of the medical research company’s stock worth $121,518,000 after acquiring an additional 1,598,108 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Analogic Corporation by 3.1% in the 2nd quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock worth $83,359,000 after acquiring an additional 34,765 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Analogic Corporation by 18.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 910,561 shares of the medical research company’s stock worth $66,153,000 after acquiring an additional 143,003 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Analogic Corporation by 1.8% in the 2nd quarter. Wells Fargo & Company MN now owns 785,205 shares of the medical research company’s stock worth $57,045,000 after acquiring an additional 14,180 shares in the last quarter. Finally, Northern Trust Corp grew its position in shares of Analogic Corporation by 53.5% in the 2nd quarter. Northern Trust Corp now owns 372,687 shares of the medical research company’s stock worth $27,075,000 after acquiring an additional 129,855 shares in the last quarter. Hedge funds and other institutional investors own 99.06% of the company’s stock.

Analogic Corporation Company Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Get a free copy of the Zacks research report on Analogic Corporation (ALOG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.